RATIONALE: Left ventricular (LV) mass and related phenotypes are heritable, important predictors of cardiovascular disease, particularly in hypertensive individuals. OBJECTIVE: Identify genetic predictors of echocardiographic phenotypes in hypertensive families. METHODS AND RESULTS: A multistage genome-wide association study (GWAS) was conducted in hypertensive-ascertained black families (HyperGEN, stage I; GENOA, stage II); findings were replicated in HyperGEN white families (stage III). Echocardiograms were collected using a common protocol, and participants were genotyped with the Affymetrix Genome-Wide Human SNP 6.0 Array. The following were analyzed using mixed models adjusted for ancestry: in stages I and II, 1258 and 989 blacks, respectively; and in stage III, 1316 whites. Phenotypes included LV mass, LV internal dimension (LVID), wall thicknesses (posterior [PWT] and intraventricular septum [IVST]), and relative wall thickness (RWT). In stage I, 5 single nucleotide polymorphisms (SNPs) had P≤10(-6). In stage II, 1 SNP (rs1436109; NCAM1 intron 1) replicated with the same phenotype (PWT, P=0.025) in addition to RWT (P=0.032). In stage III, rs1436109 was associated with RWT (P=5.47×10(-4)) and LVID (P=1.86×10(-4)). Fisher combined probability value for all stages was RWT=3.80×10(-9), PWT=3.12×10(-7), IVST=8.69×10(-7), LV mass=2.52×10(-3), and LVID=4.80×10(-4). CONCLUSIONS: This GWAS conducted in hypertensive families identified a variant in NCAM1 associated with LV wall thickness and RWT. NCAM is upregulated during the remodeling period of hypertrophy to heart failure in Dahl salt-sensitive rats. Our initial screening in hypertensive blacks may have provided the context for this novel locus.
RATIONALE: Left ventricular (LV) mass and related phenotypes are heritable, important predictors of cardiovascular disease, particularly in hypertensive individuals. OBJECTIVE: Identify genetic predictors of echocardiographic phenotypes in hypertensive families. METHODS AND RESULTS: A multistage genome-wide association study (GWAS) was conducted in hypertensive-ascertained black families (HyperGEN, stage I; GENOA, stage II); findings were replicated in HyperGEN white families (stage III). Echocardiograms were collected using a common protocol, and participants were genotyped with the Affymetrix Genome-Wide Human SNP 6.0 Array. The following were analyzed using mixed models adjusted for ancestry: in stages I and II, 1258 and 989 blacks, respectively; and in stage III, 1316 whites. Phenotypes included LV mass, LV internal dimension (LVID), wall thicknesses (posterior [PWT] and intraventricular septum [IVST]), and relative wall thickness (RWT). In stage I, 5 single nucleotide polymorphisms (SNPs) had P≤10(-6). In stage II, 1 SNP (rs1436109; NCAM1 intron 1) replicated with the same phenotype (PWT, P=0.025) in addition to RWT (P=0.032). In stage III, rs1436109 was associated with RWT (P=5.47×10(-4)) and LVID (P=1.86×10(-4)). Fisher combined probability value for all stages was RWT=3.80×10(-9), PWT=3.12×10(-7), IVST=8.69×10(-7), LV mass=2.52×10(-3), and LVID=4.80×10(-4). CONCLUSIONS: This GWAS conducted in hypertensive families identified a variant in NCAM1 associated with LV wall thickness and RWT. NCAM is upregulated during the remodeling period of hypertrophy to heart failure in Dahl salt-sensitive rats. Our initial screening in hypertensive blacks may have provided the context for this novel locus.
Authors: Pankaj Sharma; Rita P S Middelberg; Toby Andrew; Michael R Johnson; Howard Christley; Morris J Brown Journal: J Hypertens Date: 2006-02 Impact factor: 4.844
Authors: Richard V Milani; Carl J Lavie; Mandeep R Mehra; Hector O Ventura; Joshua D Kurtz; Franz H Messerli Journal: Am J Cardiol Date: 2006-02-13 Impact factor: 2.778
Authors: R R Williams; D C Rao; R C Ellison; D K Arnett; G Heiss; A Oberman; J H Eckfeldt; M F Leppert; M A Province; S C Mockrin; S C Hunt Journal: Ann Epidemiol Date: 2000-08 Impact factor: 3.797
Authors: D K Arnett; Y Hong; J N Bella; A Oberman; D W Kitzman; P N Hopkins; D C Rao; R B Devereux Journal: Am J Hypertens Date: 2001-12 Impact factor: 2.689
Authors: Edward P Havranek; Desiree B Froshaug; Caroline D B Emserman; Rebecca Hanratty; Mori J Krantz; Frederick A Masoudi; L Miriam Dickinson; John F Steiner Journal: Am J Med Date: 2008-10 Impact factor: 4.965
Authors: Yan V Sun; Alicia K Smith; Karen N Conneely; Qiuzhi Chang; Weiyan Li; Alicia Lazarus; Jennifer A Smith; Lynn M Almli; Elisabeth B Binder; Torsten Klengel; Dorthie Cross; Stephen T Turner; Kerry J Ressler; Sharon L R Kardia Journal: Hum Genet Date: 2013-05-09 Impact factor: 4.132
Authors: Maegen A Ackermann; Jennifer M Petrosino; Heather R Manring; Patrick Wright; Vikram Shettigar; Ahmet Kilic; Paul M L Janssen; Mark T Ziolo; Federica Accornero Journal: J Mol Cell Cardiol Date: 2017-09-01 Impact factor: 5.000
Authors: Anh N Do; Wei Zhao; Vinodh Srinivasasainagendra; Stella Aslibekyan; Hemant K Tiwari; Nita Limdi; Sanjiv J Shah; Degui Zhi; Uli Broeckel; C Charles Gu; D C Rao; Karen Schwander; Jennifer A Smith; Sharon L R Kardia; Donna K Arnett; Marguerite R Irvin Journal: J Hypertens Manag Date: 2017-07-20
Authors: Farah Ammous; Wei Zhao; Scott M Ratliff; Minjung Kho; Lulu Shang; Alana C Jones; Ninad S Chaudhary; Hemant K Tiwari; Marguerite R Irvin; Donna K Arnett; Thomas H Mosley; Lawrence F Bielak; Sharon L R Kardia; Xiang Zhou; Jennifer Smith Journal: Epigenetics Date: 2020-10-26 Impact factor: 4.528